| pubmed-article:8461958 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8461958 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:8461958 | lifeskim:mentions | umls-concept:C1533685 | lld:lifeskim |
| pubmed-article:8461958 | lifeskim:mentions | umls-concept:C0042580 | lld:lifeskim |
| pubmed-article:8461958 | lifeskim:mentions | umls-concept:C0015127 | lld:lifeskim |
| pubmed-article:8461958 | lifeskim:mentions | umls-concept:C0014245 | lld:lifeskim |
| pubmed-article:8461958 | lifeskim:mentions | umls-concept:C1314792 | lld:lifeskim |
| pubmed-article:8461958 | lifeskim:mentions | umls-concept:C0231174 | lld:lifeskim |
| pubmed-article:8461958 | lifeskim:mentions | umls-concept:C0205225 | lld:lifeskim |
| pubmed-article:8461958 | lifeskim:mentions | umls-concept:C0699518 | lld:lifeskim |
| pubmed-article:8461958 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:8461958 | pubmed:dateCreated | 1993-5-5 | lld:pubmed |
| pubmed-article:8461958 | pubmed:abstractText | A total of 135 consecutive patients with primary vesicoureteric reflux (VUR) were treated as day cases using submucosal Teflon injection (STING) between 1984 and 1988. Up to 3 repeat procedures were performed in the event of failure; 89% of patients and 92% of ureters were cured. None was obstructed and 2 recurred. Eight patients continue to have asymptomatic reflux Grade 2 or less, while 7 have had open surgery to correct the reflux. Most of the failures had a satisfactory appearance at STING but this deteriorated with time and appears to have been caused by leakage of Teflon from the injection site post-operatively. There were no signs or symptoms of embolisation or migration of the implant material. | lld:pubmed |
| pubmed-article:8461958 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8461958 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8461958 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8461958 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8461958 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8461958 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:8461958 | pubmed:issn | 0007-1331 | lld:pubmed |
| pubmed-article:8461958 | pubmed:author | pubmed-author:BostonV EVE | lld:pubmed |
| pubmed-article:8461958 | pubmed:author | pubmed-author:KhattarSS | lld:pubmed |
| pubmed-article:8461958 | pubmed:author | pubmed-author:BhattiH AHA | lld:pubmed |
| pubmed-article:8461958 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8461958 | pubmed:volume | 71 | lld:pubmed |
| pubmed-article:8461958 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8461958 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8461958 | pubmed:pagination | 221-5 | lld:pubmed |
| pubmed-article:8461958 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:8461958 | pubmed:meshHeading | pubmed-meshheading:8461958-... | lld:pubmed |
| pubmed-article:8461958 | pubmed:meshHeading | pubmed-meshheading:8461958-... | lld:pubmed |
| pubmed-article:8461958 | pubmed:meshHeading | pubmed-meshheading:8461958-... | lld:pubmed |
| pubmed-article:8461958 | pubmed:meshHeading | pubmed-meshheading:8461958-... | lld:pubmed |
| pubmed-article:8461958 | pubmed:meshHeading | pubmed-meshheading:8461958-... | lld:pubmed |
| pubmed-article:8461958 | pubmed:meshHeading | pubmed-meshheading:8461958-... | lld:pubmed |
| pubmed-article:8461958 | pubmed:meshHeading | pubmed-meshheading:8461958-... | lld:pubmed |
| pubmed-article:8461958 | pubmed:meshHeading | pubmed-meshheading:8461958-... | lld:pubmed |
| pubmed-article:8461958 | pubmed:meshHeading | pubmed-meshheading:8461958-... | lld:pubmed |
| pubmed-article:8461958 | pubmed:meshHeading | pubmed-meshheading:8461958-... | lld:pubmed |
| pubmed-article:8461958 | pubmed:meshHeading | pubmed-meshheading:8461958-... | lld:pubmed |
| pubmed-article:8461958 | pubmed:meshHeading | pubmed-meshheading:8461958-... | lld:pubmed |
| pubmed-article:8461958 | pubmed:meshHeading | pubmed-meshheading:8461958-... | lld:pubmed |
| pubmed-article:8461958 | pubmed:meshHeading | pubmed-meshheading:8461958-... | lld:pubmed |
| pubmed-article:8461958 | pubmed:meshHeading | pubmed-meshheading:8461958-... | lld:pubmed |
| pubmed-article:8461958 | pubmed:meshHeading | pubmed-meshheading:8461958-... | lld:pubmed |
| pubmed-article:8461958 | pubmed:year | 1993 | lld:pubmed |
| pubmed-article:8461958 | pubmed:articleTitle | Efficacy and causes of failure of endoscopic subureteric injection of Teflon in the treatment of primary vesicoureteric reflux. | lld:pubmed |
| pubmed-article:8461958 | pubmed:affiliation | Northern Ireland Paediatric Surgical Service, Royal Belfast Hospital for Sick Children. | lld:pubmed |
| pubmed-article:8461958 | pubmed:publicationType | Journal Article | lld:pubmed |
